Staphylococcus aureus is a Gram-positive coccus that commonly colonizes human skin and the anterior nares and is one of the most important bacterial pathogens in clinical microbiology.
Staphylococcus aureus is one of the most important bacterial pathogens in human medicine and can cause a broad spectrum of infections ranging from superficial skin disease to severe invasive illness.
The organism frequently colonizes the skin and nasal mucosa of healthy individuals. From these colonization sites it may invade tissues and cause infection, particularly after disruption of epithelial barriers, in immunocompromised patients, or following viral respiratory infections.
Infections of the lower respiratory tract caused by S. aureus may be severe and sometimes rapidly progressive. Before the introduction of antibiotics, staphylococcal pneumonia was associated with very high mortality, especially during influenza epidemics.
A key diagnostic feature of S. aureus is a strongly positive catalase reaction, which helps distinguish staphylococci from catalase-negative streptococci and enterococci. Coagulase positivity remains another major conventional clue in routine microbiology.
Clinical interpretation always depends on specimen type and context. Isolation from blood cultures or deep tissue samples is usually significant, whereas recovery from superficial sites may represent colonization as well as infection.
On blood agar incubated at 35–37 °C, colonies typically appear smooth, round, and opaque after 18–24 hours. Many strains produce a characteristic golden-yellow pigment known as staphyloxanthin, although pigment intensity is variable.
Gram staining reveals Gram-positive cocci arranged in irregular clusters. Cells are non-motile and non-spore-forming.
Species-level identification in clinical microbiology laboratories is commonly achieved using MALDI-TOF mass spectrometry. Automated biochemical systems and molecular assays, including PCR-based detection of species-associated or resistance-associated genes, may also be used for rapid and reliable identification.
Staphylococcus aureus displays variable susceptibility to antimicrobial agents depending on the presence of resistance mechanisms such as β-lactamase production or methicillin resistance.
Many methicillin-susceptible isolates remain susceptible to several commonly used agents, including antistaphylococcal penicillins, first-generation cephalosporins, clindamycin, and trimethoprim-sulfamethoxazole. Local susceptibility patterns, however, may differ substantially.
Methicillin-resistant S. aureus (MRSA) has major clinical and epidemiological importance because it limits empirical and targeted treatment options and may require specific infection-control measures.
Note: Antimicrobial susceptibility patterns may vary between isolates and clinical settings; antimicrobial therapy should always be guided by laboratory susceptibility testing and clinical evaluation.
For broader general information about Staphylococcus aureus, including taxonomy, history, and general biology, see:
